HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.

AuthorsMarc Brisson, James M Pellissier, Myron J Levin
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 45 Issue 11 Pg. 1527-9 (Dec 01 2007) ISSN: 1537-6591 [Electronic] United States
PMID17990240 (Publication Type: Comment, Letter)
Chemical References
  • Herpes Zoster Vaccine
Topics
  • Aged
  • Cost-Benefit Analysis
  • Herpes Zoster (prevention & control)
  • Herpes Zoster Vaccine (economics, immunology)
  • Humans
  • Neuralgia, Postherpetic (economics, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: